Read the article: Wamberg Genomic Advisors and Cancer Guardian were included in the Leader’s Edge Magazine article, A New Generation of Benefits. Read it using the link below. Read – A New Generation of Benefits
PlanSource Partners with Wamberg Genomic Advisors to Provide Convenient Access to Innovative Cancer Support Services
Read the article: PlanSource, a leading provider of benefits technology, has announced its partnership with Wamberg Genomic Advisors to offer the groundbreaking employee benefit, Cancer Guardian, to customers using the PlanSource benefits administration system. Read The Announcement
Read the article: IBM’s tools will be open-source, allowing researchers to use them in developing drugs for cancer treatments. One of the AI tools, named PaccMann, will use algorithms to predict if certain compounds may become viable anticancer drugs. Read more in the Futurism article using the button below. Read The Futurism Article
Read the article: Healthcare Tech Outlook Magazine has named Wamberg Genomic Advisors in their Top 10 Oncology Solution providers in 2019. The Top 10 Oncology Providers is an annual listing of 10 companies that are at the forefront of tackling customer challenges. Access the link below to read all about Wamberg Genomic Advisors and Cancer […]
Read the article: According to this recent American Cancer Society report, cancer prevention methods, risk screening and treatment can greatly reduce the burden of cancer in the U.S. Modifiable risk factors and effective screening can make all the difference. Explore our website for information on how Cancer Guardian can help with prevention and the possibility […]
Empower employees to identify their genetic risk in advance and address the challenges presented when dealing with cancer. Cancer Guardian solves the problem of awareness, access and affordability to services that can help improve prevention and survival. Benefits Pro has a new market insight on how cancer tops the list of high-cost insurance claims for […]
Read the article: Wamberg Genomic Advisors Executive VP, Sales & Business Development Nick Bellanca is featured on the Councilcast podcast talking about how genomic medicine is evolving healthcare. Listen to the Podcast
Join Wamberg Genomic Advisors and Cancer Guardian in remembering Dr. Henry Lynch, known as the father of cancer genetics, who has passed away at age 91.
Read the article: Wamberg Genomic Advisors Executive VP, Sales & Business Development Nick Bellanca talks with Leader’s Edge Magazine about genetic products and services as part of employer benefit packages. Read The Q & A
Healthcare executives understand that cancer patients and their families are going through a difficult and challenging time. During this period, providing patients with access to guidance from knowledgeable experts can go a long way toward easing their frustrations.